LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
11.91
-0.12 (-1.00%)
Oct 1, 2026, 4:00 PM EDT - Market closed
LifeStance Health Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,585 | 1,424 | 1,251 | 1,056 | 859.54 | 667.51 | |
Revenue Growth | 20.38% | 13.85% | 18.50% | 22.82% | 28.77% | 76.96% |
Cost of Revenue | 1,053 | 963.19 | 848.57 | 753.57 | 622.53 | 466 |
Gross Profit | 531.85 | 461.1 | 402.4 | 302.1 | 237.02 | 201.51 |
Selling, General & Admin | 396.85 | 381.18 | 360.32 | 343.27 | 373.43 | 431.13 |
Operating Expenses | 451.4 | 435.93 | 431.27 | 423.7 | 442.63 | 485.26 |
Operating Income | 80.45 | 25.17 | -28.87 | -121.61 | -205.61 | -283.76 |
Interest Expense | -10.11 | -11.66 | -26.54 | -21.22 | -19.93 | -38.91 |
Other Non Operating Income (Expenses) | -0.31 | -0.12 | -0.36 | -0.11 | -0.22 | -0.26 |
EBT Excluding Unusual Items | 70.03 | 13.38 | -55.77 | -142.94 | -225.75 | -322.92 |
Merger & Restructuring Charges | -0.86 | 0.13 | -1.91 | -15.69 | -3.05 | -6.07 |
Legal Settlements | -1.15 | -1.15 | -1.59 | -51.03 | -0.85 | - |
Other Unusual Items | -1.03 | - | 1.65 | 3.08 | -3.08 | -4.12 |
Pretax Income | 66.99 | 12.36 | -57.61 | -206.58 | -232.73 | -333.11 |
Income Tax Expense | 16.39 | 2.7 | -0.17 | -20.32 | -17.17 | -25.91 |
Net Income | 50.6 | 9.66 | -57.44 | -186.26 | -215.56 | -307.2 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 36.75 |
Net Income to Common | 50.6 | 9.66 | -57.44 | -186.26 | -215.56 | -343.95 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 386 | 386 | 379 | 367 | 355 | 328 |
Shares Outstanding (Diluted) | 394 | 391 | 379 | 367 | 355 | 328 |
Shares Change | 3.01% | 3.16% | 3.18% | 3.43% | 8.47% | 8.33% |
EPS (Basic) | 0.13 | 0.03 | -0.15 | -0.51 | -0.61 | -1.05 |
EPS (Diluted) | 0.13 | 0.02 | -0.15 | -0.51 | -0.61 | -1.05 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 173.91 | 110.03 | 85.69 | -57.4 | -26.47 | -85.07 |
Free Cash Flow Per Share | 0.44 | 0.28 | 0.23 | -0.16 | -0.07 | -0.26 |
Gross Margin | 33.56% | 32.37% | 32.17% | 28.62% | 27.57% | 30.19% |
Operating Margin | 5.08% | 1.77% | -2.31% | -11.52% | -23.92% | -42.51% |
Profit Margin | 3.19% | 0.68% | -4.59% | -17.64% | -25.08% | -51.53% |
Free Cash Flow Margin | 10.97% | 7.72% | 6.85% | -5.44% | -3.08% | -12.75% |
EBITDA | 135.01 | 79.92 | 42.08 | -41.17 | -136.41 | -229.62 |
EBITDA Margin | 8.52% | 5.61% | 3.36% | -3.90% | -15.87% | -34.40% |
D&A For EBITDA | 54.56 | 54.75 | 70.95 | 80.44 | 69.2 | 54.14 |
EBIT | 80.45 | 25.17 | -28.87 | -121.61 | -205.61 | -283.76 |
EBIT Margin | 5.08% | 1.77% | -2.31% | -11.52% | -23.92% | -42.51% |
Effective Tax Rate | 24.47% | 21.84% | - | - | - | - |
Advertising Expenses | - | 15.82 | 12.57 | 9.4 | 8.63 | - |